Evidence map›Paper›PMID 37365735›Full record

ArticleYonsei medical journal2023

Impact of Atrial Fibrillation on Patients Undergoing Transcatheter Aortic Valve Implantation (TAVI): The K-TAVI Registry.

Sang Yoon Lee, Ki Hong Choi, Taek Kyu Park, Jihoon Kim, Eun Kyoung Kim, Sung-Ji Park, Seung Woo Park, Hyeon-Cheol Gwon, Kiyuk Chang, Cheol Woong Yu and 19 more

Abstract read
In one paragraph

Article in Yonsei medical journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Less Symptom Improvement in Patients Undergoing TAVI With Concomitant COPD, Atrial Fibrillation and Heart Failure.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2025
    Article
  4. Article
  5. Review
  6. Observational
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Sang Yoon Lee *Division of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-4359-2136
Ki Hong Choi *Division of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0001-7511-9581
Taek Kyu ParkDivision of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0003-1440-3583
Jihoon KimDivision of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-6919-446X
Eun Kyoung KimDivision of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-0849-3300
Sung-Ji ParkDivision of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-7075-847X
Seung Woo ParkDivision of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-0818-8816
Hyeon-Cheol GwonDivision of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-4902-5634
Kiyuk ChangDivision of Cardiology, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.ORCID https://orcid.org/0000-0003-3456-8705
Cheol Woong YuDivision of Cardiology, Department of Internal Medicine, Cardiovascular Center, Korea University Anam Hospital, Seoul, Korea.ORCID https://orcid.org/0000-0002-5871-4562
JuHan KimHeart Center of Chonnam National University Hospital, Gwangju, Korea.ORCID https://orcid.org/0000-0002-3186-0770
Young Jin ChoiCardiology, Cardiovascular Center, Sejong General Hospital, Bucheon, Korea.ORCID https://orcid.org/0000-0003-3701-9584
In-Ho ChaeDivision of Cardiology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.ORCID https://orcid.org/0000-0003-2091-6764
Jae-Hwan LeeDepartment of Cardiology, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, Korea.ORCID https://orcid.org/0000-0002-5313-1931
Jun-Hong KimDivision of Cardiology, Department of Internal Medicine and Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Busan, Korea.ORCID https://orcid.org/0000-0003-4208-0814
Jong Seon ParkDepartment of Medicine, Yeungnam University Hospital, Daegu, Korea.ORCID https://orcid.org/0000-0002-2958-026X
Won-Jang KimDepartment of Cardiology, CHA Bundang Medical Center, CHA University, Seongnam, Korea.ORCID https://orcid.org/0000-0002-9915-3722
Young Won YoonDivision of Cardiology, Heart Center, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-0907-0350
Tae Hoon AhnCardiology, Gachon University Gil Medical Center, Incheon, Korea.ORCID https://orcid.org/0000-0003-1544-1784
Sang Rok LeeDivision of Cardiology, Department of Internal Medicine, Chonbuk National University Hospital, Jeonju, Korea.ORCID https://orcid.org/0000-0002-5845-2232
Byoung Joo ChoiDepartment of Cardiology, Ajou University Medical Center, Suwon, Korea.ORCID https://orcid.org/0000-0002-3045-5343
Tae-Hyun YangDepartment of Cardiology, Busan Paik Hospital, University of Inje College of Medicine, Busan, Korea.ORCID https://orcid.org/0000-0003-1594-3696
Cheol Ung ChoiCardiovascular Center, Division of Cardiology, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0003-2815-9358
Seung-Ho HurDepartment of Internal Medicine, Keimyung University Dongsan Medical Center, Daegu, Korea.ORCID https://orcid.org/0000-0002-3895-1915
Seong-Jin OhDivision of Cardiology, National Health Insurance Service Ilsan Hospital, Goyang, Korea.ORCID https://orcid.org/0000-0003-4057-9398
Han Cheol LeeDepartment of Cardiology and Medical Research Institute, Pusan National University Hospital, Busan, Korea.ORCID https://orcid.org/0000-0002-7236-4204
HunSik ParkDepartment of Internal Medicine, Kyungpook National University Hospital, Daegu, Korea.ORCID https://orcid.org/0000-0001-7138-1494
Hyo-Soo KimDepartment of Internal Medicine, Cardiology Centre, Seoul National University Hospital, Seoul, Korea.ORCID https://orcid.org/0000-0003-2977-6323
Seung-Hyuk ChoiDivision of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. sh1214.choi@samsung.com.ORCID https://orcid.org/0000-0002-0304-6317

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe incidence and prognostic implications of atrial fibrillation (AF) in patients with severe aortic stenosis (AS) undergoing transcatheter aortic valve implantation (TAVI) are controversial, especially for Korean patients. Furthermore, the pattern of antithrombotic therapy for these patients is unknown. The present study sought to identify the impact of AF on Korean patients undergoing TAVI and demonstrate the status of antithrombotic therapy for these patients. MATERIALS AND

methodsA total of 660 patients who underwent TAVI for severe AS were recruited from the nationwide K-TAVI registry in Korea. The enrolled patients were stratified into sinus rhythm (SR) and AF groups. The primary endpoint was all-cause death at 1-year.

resultsAF was recorded in 135 patients [pre-existing AF 108 (16.4%) and new-onset AF 27 (4.1%)]. The rate of all-cause death at 1 year was significantly higher in patients with AF than in those with SR [16.2% vs. 6.4%, adjusted hazard ratio (HR): 2.207, 95% confidence interval (CI): 1.182-4.120,

conclusionAF was an independent predictor of 1-year mortality and new pacemaker insertion in Korean patients undergoing TAVI.

Indexed as

Aortic Valve StenosisAtrial FibrillationTranscatheter Aortic Valve ReplacementAortic ValveFibrinolytic AgentsHumansPrognosisRegistriesRisk FactorsTreatment OutcomeFibrinolytic Agentsantithrombotic agentatrial fibrillationKoreanTranscatheter aortic valve implantation

Identifiers

PMID37365735
PMCPMC10307679

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.